江苏快3

万维书刊网微信二维码

江苏快3扫微信,关注编辑QQ!

您的位置:万维书刊网 >>期刊大全 >>医药卫生综合>>本科学报(医卫)

药物分析学报期刊_投稿邮箱_杂志_编辑部_审稿_投稿须晓

简介
《药物分析学报(英文版)》(Journal of Pharmaceutical Analysis)(双月刊)是世界上第一份有关药物分析的专业学术期刊,主编由西安交通大学医学院药物研究所所长、中国药学会药物分析专业委员会主任委员贺浪冲教授担任。JPA目前被美国《化学文摘》(CA)和荷兰《医学文摘》(EM)收录,并进入中文科技期刊数据库、万方数据库、中国学术光盘数据库(CNKI) 和复庆维普数据库等多...[显示全部]
本刊为:CSCD核心(2019-2020), 维普收录, 万方收录, 晓网收录,第一批认定学术期刊,外文期刊,
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、刊内网址:

投稿系统:

3、刊内邮箱:jpa2011@126.com

jpasubmit@126.com

jpa2011@xjtu。edu。cn

4、刊内电话:029-8265543382655412

5、出刊日期:双月刊,逢双月出版。

2019516日星期四

                            

 

《药物分析学报(英文)》作者指南

201901期信息】

 

Instructions to Authors

Journal of Pharmaceutical Analysis

An international journal providing a forum for original and pertinent contributions in Pharmaceutical Analysis。

Types of papers

Journal of Pharmaceutical Analysis welcomes submissions of fulllength reviews, original research articles and short communication. The act of submitting a manuscript to the Journal carries with it the right to publish that paper.

Journal of Pharmaceutical Analysis is published to attract and disseminate innovative and expert findings in the fields:

(1) Analysis of traditional Chinese medicine (medicinal materials, patent medicine, prescription, injection)

(2) Pharmaceutical analysis of complex system

(3) Quality control and methods of biotech drugs

(4) Action mechanism and their metabolisms in body

(5) Quantitative and qualitative analysis in the drug screening process

(6) Tracer analysis in molecular pharmacology

(7) Quantitative analysis in biopharmaceutics

(8) Clinical laboratory and bioanalysis

(9) Analysis of pharmacological activity

(10) Analysis of drug toxicity

(11) Analytical chemistry techniques and methods

(12) New biochemistry methods for pharmaceutical analysis

(13) Rapid screening methods

(14) New analytical techniques and methods

(15) Others: Small drug molecules, Pharmaceutical solid materials (including biomaterials, polymers and nanoparticles), Biotechnology products (including genes, peptides, proteins and vaccines), and Engineered cells.

Ethics and procedures

The editors and publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal “code of conduct”, these fundamental principles with respect to the authors’ paper are that the paper should:

* be the authors’ own original work, which has not been previously published elsewhere,

* reflect the authors’ own research and analysis and do so in a truthful and complete manner,

* properly credit the meaningful contributions of co-authors and co-researchers,

* not be submitted to more than one journal for consideration (ensuring it is not under redundant simultaneous peer review), and * be appropriately placed in the context of prior and existing research.

Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding。 While it may not be possible to draft a “code” that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the Journal will employ in the event of questions concerning author conduct。 Relevant conflicts of interest should J Pharm Anal https://www。evise。com/profile/api/navigate/JPA be disclosed (see http://www。elsevier。com/wps/find/authorshome。authors/conflictsofinterest)。

Studies involving experiments with animals must state that their care was in accordance with institution guidelines.

Submission of manuscripts

Journal of Pharmaceutical Analysis has moved to an online submission and review system. Manuscripts should be submitted online at https://www.evise.com/profile/api/navigate/JPA and the instructions on the site should be closely followed. Authors may submit manuscripts and track their progress through to final decision.

Reviewers can download manuscripts and submit their reports to the Managing Editors。

Authors unable to submit online should contact the Editorial Office:

Journal of Pharmaceutical Analysis Editorial Office

76 Yanta West Road, Xi’an, Shaanxi, 710061, P.R. China

Tel: +86 (0)29 82655433, +86 (0)29 82655412

Email: jpa2011@126.com, jpasubmit@126.com, jpa2011@xjtu.edu.cn

Submission of an article to Journal of Pharmaceutical Analysis implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or any other language, without the written consent of the Publisher.

Manuscripts should be in English. Authors’ full names, academic or professional affiliations, and addresses should be included on the first page. All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or the acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted. The name, postal address and email address of the corresponding author should be provided. Authors should supply the names and email addresses of 3 potential reviewers for their manuscript. To provide an international perspective, no more than 2 potential reviewers should be from the same country. Please do not suggest reviewers from your own institution, previous or current collaborators or Editorial Board members. Without reviewer suggestions, processing of the manuscript may be delayed. Please do not contact any reviewers that you have suggested.

Online submission guidelines can be followed at https://www。evise。com/profile/api/navigate/JPA。 Via this website you will be guided stepwise through the creation and uploading of the various files。 The system automatically converts source files into a single Adobe Acrobat PDF version of the article, which is used in the peer review process。 Please note that although manuscript source files are converted to PDF at submission for the review process, these source files are needed for further processing after acceptance。

All correspondence, including notification of the Editor’s decision and requests for revision, takes place by email and via the author’s homepage, removing the need for a hard-copy paper trail.

Peer review

This Journal operates a single blind review process. All contributions are sent to a minimum of two independent expert reviewers to assess the scientifi c quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor’s decision is fi nal. For more information on the types of peer review, please visit: http://www.elsevier.com/reviewers/peer-review.

Manuscript preparation

Please strive for a professionally prepared manuscript of high technical and scientific quality. Many reviewers are overwhelmed with review requests. Our experience is that they are more likely to agree to review a well prepared manuscript.

Articles should be submitted in the following order : Title, Abstract, Introduction, Materials and methods (or Experimental), Results and discussion, Acknowledgments, References.

Please number the headings in your manuscript as follows:

1. Introduction; 2. Materials and methods (or Experimental); 3. Results and discussion; 4. Conclusion, etc.; with further numbering for subheadings (e.g.1.1, 1.2, etc) as required.

All submissions must be accompanied by a covering letter in which the signifi cance of the results is outlined in no more than 5 sentences.

Title must address the main result of the study and preferably not exceed 185 characters, including spaces。 Extraneous words such as study’ ‘investigation’, ‘analysis’, etc, should be avoided.

Abstract. A concise and factual abstract not exceeding 200 is required, followed by 3-8 indexing terms (keywords). The abstract should briefl y state the purpose of the research, the principal results and major conclusions. An abstract is often presented separately from the article, so it must be able to stand alone.

Tables should be typed, with double spacing, each on a separate sheet, numbered consecutively with Roman numerals, and should only contain horizontal lines. A short descriptive heading should be given above each table, and any footnotes and explanations underneath.

Figures must be numbered and keyed into the text。 For advice on correctly formatting electronic images, please refer to http://authors。elsevier。com。 For illustrations that cannot be submitted electronically, please send them by post to the Editorial Offi ce。 The author’s name, the figure number and an arrow identifying orientation should be appended to the reverse of each illustration。 Line drawings (including graphs) must be in black ink on a white background。 Alternatively, sharp photographs on glossy paper may be provided。 The lettering should be large enough to permit photographic reproduction。 Halftone illustrations may be included, which should be submitted as black and white prints on glossy paper and have as much contrast as possible。 All legends should be typed on a separate sheet of paper。 Composite illustrations should be sensibly and compactly arranged as a plate, without leaving much empty white space between the different elements。

Illustrations should be designed for use in either a single column (7.5 cm) or a double column (16 cm). Actual magnification of all photomicrographs should be indicated by a micron bar or in the legend.

Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Offi ce fi les) and with the correct resolution。 If, together with your accepted article, you submit usable electronic colour fi gures then Elsevier will ensure, at no additional charge, that these figures will appear in colour on the Web (e。g。 ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in colour in the printed version。 For colour reproduction SCIE/Web of Science in print, you will receive information regarding the costs from Elsevier after receipt of your accepted article。 Please indicate your preference for colour in print or on the Web only。 For further information on the preparation of electronic artwork, please see http://authors。elsevier。com/artwork。

Acknowledgments. All contributors who do not meet the criteria for authorship as defi ned above should be listed in an acknowledgments section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a departmental chair who provided only general support. Authors should disclose whether they had any writing assistance and identify the entity that paid for that assistance.

Conflict of interest. At the end of the text, under a subheadingConflict of Interest Statement”, all authors must disclose any financial and personal relationships with other people or organisations that could innapropriately infl uence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.

Role of the funding source. All sources of funding should be declared as an Acknowledgment at the end of the text. Authors should declare the role of the study sponsors, if any, in the study design, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. If the study sponsors had no such involvement, the authors should so state.

References should be numbered and listed on a separate sheet. Indicate references by number(s) in square brackets in line with the text. The actual authors can be referred to, but the reference number(s) must always be given.

Example: “?.. as demonstrated [3,4]. Barnaby and Jones [5] obtained a different result?.”

List: Number the references (numbers in square brackets) in the list in the order in which they appear in the text.

Examples:

Reference to a journal publication:

[1] J. van der Geer, J.A.J. Hanraads, R.A. Lupton, et al., The art of writing a scientifi c article, J. Sci. Commun. 163 (2000): 51-59.

Reference to a book:

[2] W. Strunk Jr, E.B. White, The Elements of Style, third ed., Macmillan, New York, 1979.

Reference to a chapter in an edited book:

[3] G.R. Mettam, L.B. Adams, How to prepare an electronic version of your article. B.S. Jones, R.Z. Smith, Introduction to the Electronic Age, E-Publishing Inc., New York, 1999: 281-304.

Supplementary data is accepted by Journal of Pharmaceutical Analysis to support and enhance your scientific research.

Supplementary files offer the author additional responsibilities to publish supporting applications, movies, animation sequences, high-resolution images, background datasets, sound clips and more. Supplementary files will be published online alongside the electronic version of your article in Elsevier Web products, including ScienceDirect: http://www.sciencedirect.com. In order to ensure that your submitted material is directly usable, please ensure that data is provided in one of our recommended file formats. Authors should submit the material in electronic format together with the article and supply a concise and descriptive caption for each fi le. For more detailed instructions, please visit our artwork instruction pages at the

Author Gateway at http://authors。elsevier。com/artwork。


投稿问答最小化  关闭

大发时时彩 pk10开奖记录 pk10投注 江苏快3 pk10注册平台

免责声明: 本站资料及图片来源互联网文章-|,本网不承担任何由内容信息所引起的争议和法律责任-。所有作品版权归原创作者所有,与本站立场无关-|,如用户分享不慎侵犯了您的权益,请联系我们告知,-|我们将做删除处理!